Search
for
Sort by
Research 61–90 of 687
- Dermatologic Adverse Events from Cancer Treatments
- Mucocutaneous reactions to chemotherapy
- The PDGF/PDGFR pathway as a drug target
- Dermatological adverse events with taxane chemotherapy
- Obesity and the skin
- Cutaneous reactions to recombinant cytokine therapy
- Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature
- THE DISEASE SPECTRUM, EPIDEMIOLOGY, AND ETIOLOGY OF TOXIC-SHOCK SYNDROME
- The dark art of light measurement: accurate radiometry for low-level light therapy
- PHYSIOLOGIC SKIN CHANGES ASSOCIATED WITH PREGNANCY
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- TOXIC EPIDERMAL NECROLYSIS
- Toxic shock syndrome: Recent developments in pathogenesis
- Syphilis: A great imitator
- Fractional resurfacing in the Asian patient: Current state of the art
- Cutaneous Lesions in Systemic Lupus Erythematosus
- Resveratrol derivatives: a patent review (2009 – 2012)
- Dermatologic manifestations of COVID‐19: a comprehensive systematic review
- Hair Loss in Children
- Skin signs of systemic diseases
- Case 21-2012
- Medicinal Plants and their Constituents in the Treatment of Acne vulgaris
- Rejuvenation of the male scalp using 1,927 nm non-ablative fractional thulium fiber laser
- Clinical picture of infectious syphilis
- Drug eruptions in dermatology
- Dermal Mucinosis in the Eosinophilia-Myalgia Syndrome
- Psychotropic Medications and the Skin
- Adverse cutaneous effects of psychotropic medications
- The spectrum of nephrocutaneous diseases and associations
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases